These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10507606)

  • 1. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects.
    Mathur VS; Swan SK; Lambrecht LJ; Anjum S; Fellmann J; McGuire D; Epstein M; Luther RR
    Crit Care Med; 1999 Sep; 27(9):1832-7. PubMed ID: 10507606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status.
    O'Connell DP; Ragsdale NV; Boyd DG; Felder RA; Carey RM
    Hypertension; 1997 Jan; 29(1 Pt 1):115-22. PubMed ID: 9039090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics.
    Allison NL; Dubb JW; Ziemniak JA; Alexander F; Stote RM
    Clin Pharmacol Ther; 1987 Mar; 41(3):282-8. PubMed ID: 2880688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial.
    O'Hara JF; Mahboobi R; Novak SM; Bonilla AM; Mascha EJ; Fergany AF; Campbell SC; Kaouk JH; Kaple KM; Gill IS; Ziegman SA; Sessler DI
    Urology; 2013 Feb; 81(2):340-5. PubMed ID: 23374797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs.
    Halpenny M; Markos F; Snow HM; Duggan PF; Gaffney E; O'Connell DP; Shorten GD
    Crit Care Med; 2001 Apr; 29(4):855-60. PubMed ID: 11373482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers.
    Hoogenberg K; Smit AJ; Girbes AR
    Crit Care Med; 1998 Feb; 26(2):260-5. PubMed ID: 9468162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
    Shusterman NH; Elliott WJ; White WB
    Am J Med; 1993 Aug; 95(2):161-8. PubMed ID: 8102835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fenoldopam mesylate on systemic hemodynamics and indices of renal function in normotensive neonatal foals.
    Hollis AR; Ousey JC; Palmer L; Stoneham SJ; Corley KT
    J Vet Intern Med; 2006; 20(3):595-600. PubMed ID: 16734095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects.
    Taylor AA; Shepherd AM; Polvino W; Mangoo-Karim R; Ballard K; Sunthornyothin S; Luther RR; Pool JL
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):906-14. PubMed ID: 10509549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats.
    Stephens CT; Jandhyala BS
    Clin Exp Hypertens; 2002 May; 24(4):301-13. PubMed ID: 12069360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenoldopam, a selective dopamine-1 receptor agonist, raises intraocular pressure in males with normal intraocular pressure.
    Piltz JR; Stone RA; Boike S; Everitt DE; Shusterman NH; Audet P; Zariffa N; Jorkasky DK
    J Ocul Pharmacol Ther; 1998 Jun; 14(3):203-16. PubMed ID: 9671428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced regional and global cerebral blood flow during fenoldopam-induced hypotension in volunteers.
    Prielipp RC; Wall MH; Groban L; Tobin JR; Fahey FH; Harkness BA; Stump DA; James RL; Cannon MA; Bennett J; Butterworth J
    Anesth Analg; 2001 Jul; 93(1):45-52. PubMed ID: 11429337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man.
    Harvey JN; Worth DP; Brown J; Lee MR
    Br J Clin Pharmacol; 1985 Jan; 19(1):21-7. PubMed ID: 2858215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial.
    Morelli A; Ricci Z; Bellomo R; Ronco C; Rocco M; Conti G; De Gaetano A; Picchini U; Orecchioni A; Portieri M; Coluzzi F; Porzi P; Serio P; Bruno A; Pietropaoli P
    Crit Care Med; 2005 Nov; 33(11):2451-6. PubMed ID: 16276165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and renal profile of acute peripheral dopamine1-receptor agonism with fenoldopam.
    Glück Z; Jossen L; Weidmann P; Gnädinger MP; Peheim E
    Hypertension; 1987 Jul; 10(1):43-54. PubMed ID: 2885268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fenoldopam mesylate on central hemodynamics and renal flow in patients undergoing cardiac surgery: color Doppler echocardiographic evaluation.
    Meco M; Cirri S
    J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):58-62. PubMed ID: 19553140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
    Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of norepinephrine and combined norepinephrine and fenoldopam infusion on systemic hemodynamics and indices of renal function in normotensive neonatal foals.
    Hollis AR; Ousey JC; Palmer L; Stephen JO; Stoneham SJ; Boston RC; Corley KT
    J Vet Intern Med; 2008; 22(5):1210-5. PubMed ID: 18638020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group.
    Tumlin JA; Dunbar LM; Oparil S; Buckalew V; Ram CV; Mathur V; Ellis D; McGuire D; Fellmann J; Luther RR
    Acad Emerg Med; 2000 Jun; 7(6):653-62. PubMed ID: 10905644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization.
    Teirstein PS; Price MJ; Mathur VS; Madyoon H; Sawhney N; Baim DS
    Am J Cardiol; 2006 Apr; 97(7):1076-81. PubMed ID: 16563920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.